Drug Profile
Sunepitron
Alternative Names: CP 93393Latest Information Update: 05 Sep 2000
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action 5-HT1A serotonin receptor agonists; Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 05 Sep 2000 Discontinued-III for Anxiety disorders in USA (Unknown route)
- 05 Sep 2000 Discontinued-III for Depression in USA (Unknown route)
- 23 Jun 2000 Pfizer has merged with Warner-Lambert